A PARP2 active site helix melts to permit DNA damage-induced enzymatic activation
Molecular Cell · 2025-03 · 85 (5) · 865-876.e4
DOI: 10.1016/j.molcel.2025.01.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025-03. Verfasst von Emily S Smith-Pillet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Penn Center for Genome Integrity, Epigenetics Institute, Perelman School of Medicine, University of Pennsy…. Hauptthemen laut MEDLINE: DNA Damage, Poly(ADP-ribose) Polymerases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
Poly(ADP-ribose) polymerase 1 (PARP1) and PARP2 recognize DNA breaks immediately upon their formation, generate a burst of local PARylation to signal their location, and are co-targeted by all current FDA-approved forms of PARP inhibitors (PARPi) used in the cancer clinic. Recent evidence indicates that the same PARPi molecules impact PARP2 differently from PARP1, raising the possibility that allosteric activation may also differ. We find that, unlike for PARP1, destabilization of the autoinhibitory domain of PARP2 is insufficient for DNA damage-induced catalytic activation. Rather, PARP2 activation requires further unfolding of an active site helix. In contrast, the corresponding helix in PARP1 only transiently forms, even prior to engaging DNA. Only one clinical PARPi, Olaparib, stabilizes the PARP2 active site helix, representing a structural feature with the potential to discriminate small molecule inhibitors. Collectively, our findings reveal unanticipated differences in local structure and changes in activation-coupled backbone dynamics between human PARP1 and PARP2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Biophysics, Penn Center for Genome Integrity, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19140-6059, USA; Graduate Program in Biochemi…
- Department of Biochemistry and Biophysics, Penn Center for Genome Integrity, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19140-6059, USA.
- Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, QC H3C 3J7, Canada.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Förderung
- NCI NIH HHS
- National Institutes of Health
- National Institutes of Health National Cancer Institute
Zitieren
APA
Smith-Pillet, E. S., Billur, R., Langelier, M. F., Talele, T. T., Pascal, J. M., & Black, B. E. (2025). A PARP2 active site helix melts to permit DNA damage-induced enzymatic activation. Molecular Cell, 85(5), 865-876.e4. https://doi.org/10.1016/j.molcel.2025.01.004
Vancouver
Smith-Pillet ES, Billur R, Langelier MF, Talele TT, Pascal JM, Black BE. A PARP2 active site helix melts to permit DNA damage-induced enzymatic activation. Molecular Cell. 2025;85(5):865-876.e4. doi:10.1016/j.molcel.2025.01.004
BibTeX
@article{SmithPillet2025,
author = {Smith-Pillet, Emily S and Billur, Ramya and Langelier, Marie-France and Talele, Tanaji T and Pascal, John M and Black, Ben E},
title = {A PARP2 active site helix melts to permit DNA damage-induced enzymatic activation},
journal = {Molecular Cell},
year = {2025},
volume = {85},
number = {5},
pages = {865--876.e4},
doi = {10.1016/j.molcel.2025.01.004}
}
EUVIMED